LUM is the hub gene of advanced fibrosis in nonalcoholic fatty liver disease patients

被引:7
|
作者
Chang, Yue [1 ,2 ]
He, Jiange [1 ]
Xiang, Xiaohui [2 ]
Li, Hai [2 ]
机构
[1] Logist Univ Peoples Armed Ploce Force, Grad Sch, Tianjin 300162, Peoples R China
[2] Tianjin Xiqing Hosp, Div Gastroenterol & Hepatol, 403 Xiqing Rd, Tianjin 300380, Peoples R China
关键词
Nonalcoholic fatty liver disease; Gene; Coexpression network; Pathway; LUM;
D O I
10.1016/j.clinre.2020.04.006
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Introduction. - Advanced fibrosis in nonalcoholic fatty liver disease (NAFLD) is associated with a poor prognosis. The genetic factors contributing to fibrosis in NAFLD have been described. However, the genetic mechanism and hub genes of advanced fibrosis have not been elucidated to date. In this study, we performed a weighted gene coexpression network analysis (WGCNA) to identify the hub genes related to advanced fibrosis in NAFLD. Materials and methods. - The datasets GSE89632 and GSE31803 of NAFLD patients were selected from the Gene Expression Omnibus (GEO) database of NCBI and analyzed by WGCNA. The hub genes were selected in the GSE31803 dataset and verified in the GSE31803 dataset. Gene Ontology (GO) term enrichment and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis of the dataset were also performed. Results. - The gene LUM was identified as the hub gene in the datasets GSE89632 and GSE31803 according to three different algorithms (gene significance and module membership, the pathways of the genes, and protein expressed by the genes). The functional enrichment analysis shows that the identified module is related to the extracellular matrix, regulation of cell proliferation, and the inflammatory response. The metabolic pathway analysis identified metabolic pathways and focal adhesion as the most important pathways. Conclusion. - By a variety of methods, LUM was identified as the hub gene of advanced fibrosis in patients with NAFLD. Therefore, further research on the LUM gene is warranted. (c) 2020 L'Auteur(s). Publi ' e par Elsevier Masson SAS. Cet article est publi ' e en Open Access sous licence CC BY-NC-ND (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Advanced Liver Fibrosis Predicts CKD Development in Patients with Nonalcoholic Fatty Liver Disease
    Jung, Chan-Young
    Kim, Hyung Woo
    Kim, Beom Seok
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 687 - 687
  • [2] A novel model for detecting advanced fibrosis in patients with nonalcoholic fatty liver disease
    Yang, Xinyu
    Xia, Mingfeng
    Chang, Xinxia
    Zhu, Xiaopeng
    Sun, Xiaoyang
    Yang, Yinqiu
    Wang, Liu
    Liu, Qiling
    Zhang, Yuying
    Xu, Yanlan
    Lin, Huandong
    Liu, Lin
    Yao, Xiuzhong
    Hu, Xiqi
    Gao, Jian
    Yan, Hongmei
    Gao, Xin
    Bian, Hua
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2022, 38 (08)
  • [3] Prediction of advanced fibrosis in morbidly obese patients with nonalcoholic fatty liver disease
    Singh, Tavankit
    Rocio, Lopez
    Dasarathy, Srinivasan
    McCullough, Arthur J.
    HEPATOLOGY, 2017, 66 : 1123A - 1124A
  • [4] Effects of intragastric balloon in patients with nonalcoholic fatty liver disease and advanced fibrosis
    Salomone, Federico
    Currenti, Walter
    Magri, Giovanni
    Boskoski, Ivo
    Zelber-Sagi, Shira
    Galvano, Fabio
    LIVER INTERNATIONAL, 2021, 41 (09) : 2112 - 2116
  • [5] Nonalcoholic fatty liver disease with advanced fibrosis, stroke and cardiovascular disease
    Kawada, Tomoyuki
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2020, 408
  • [6] Non-invasive predictors of advanced liver fibrosis in patients with nonalcoholic fatty liver disease
    Bruining, DH
    Arodak, B
    Silverman, AL
    Gordon, SC
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S110 - S111
  • [7] Exploring factors related to clinically advanced fibrosis in patients with nonalcoholic fatty liver disease or nonalcoholic steatohepatitis
    Yu, Anthony
    Ritenour, Alexandra
    Vincent, Jennifer
    Park, Chanhyun
    Rascati, Karen
    Godley, Paul
    POSTGRADUATE MEDICINE, 2024, 136 (01) : 14 - 21
  • [8] Performance of the Enhanced Liver Fibrosis Test to Estimate Advanced Fibrosis Among Patients With Nonalcoholic Fatty Liver Disease
    Younossi, Zobair M.
    Felix, Sean
    Jeffers, Thomas
    Younossi, Elena
    Nader, Fatema
    Pham, Huong
    Afendy, Arian
    Cable, Rebecca
    Racila, Andrei
    Younoszai, Zahra
    Lam, Brian P.
    Golabi, Pegah
    Henry, Linda
    Stepanova, Maria
    JAMA NETWORK OPEN, 2021, 4 (09)
  • [9] IMPACT OF TYPE 2 DIABETES ON NONALCOHOLIC STEATOHEPATITIS AND ADVANCED FIBROSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE
    Bian, Hua
    Zhu, Xiaopeng
    Xia, Mingfeng
    Yan, Hongmei
    Chang, Xinxia
    Hu, Xiqi
    Pan, Baishen
    Guo, Wei
    Li, Xiaoying
    Gao, Xin
    ENDOCRINE PRACTICE, 2020, 26 (04) : 444 - 453
  • [10] Evaluation of fibrosis in patients with nonalcoholic fatty liver disease
    Montano-Loza, Aldo J.
    REVISTA DE GASTROENTEROLOGIA DE MEXICO, 2022, 87 (01): : 1 - 3